OMNOVA Solutions Inc

OMNOVA Solutions — Investor Presentation (September 2016)

37 slides from OMNOVA Solutions's investor presentation, Sep 22, 2016

  1. Slide 1: Why OMNOVA Solutions? A Look Forward 3rd Quarter 2016

    COMPANY CONFIDENTIAL Why OMNOVA Solutions? A Look Forward 3rd Quarter 2016 Investor Presentation Global Innovator of Performance-Enhancing Chemistries and Surfaces Exhibit 99.1

  2. Slide 2: Cautionary Statements

    COMPANY CONFIDENTIAL Cautionary Statements 2 Forward-Looking Statements This presentation includes descriptions of OMNOVA's current business, operations, assets and other matters affecting the Company as well as "forward-looking statements" as defined by federal securities laws. All forward-looking

  3. Slide 3: With OMNOVA Products... Diapers Are More Absorbent

    With OMNOVA Products... DIAPERS ARE MORE ABSORBENT.

  4. Slide 4: With OMNOVA Products... Restaurants and Retail Environments Look Better

    With OMNOVA Products... RESTAURANTS AND RETAIL ENVIRONMENTS LOOK BETTER, ONGER, AND COST LES ae

  5. Slide 5: With OMNOVA Products... Buildings

    With OMNOVA Products... BUILDINGS) OLD SAND CANBE ae R LIMATES AND C

  6. Slide 6: With OMNOVA Products...

    With OMNOVA Products... OF ce

  7. Slide 7: Countless Consumer and Commercial Brands Depend on OMNOVA

    COUNTLESS CONSUMER AND COMMERCIAL BRANDS DEPEND ON OMNOVA TO GAIN THAT SPECIAL EDGE IN PERFORMANCE. Automotive t ~ \ysFood Semvide) )

  8. Slide 8: OMNOVA Solutions Today

    COMPANY CONFIDENTIAL OMNOVA Solutions Today Global innovator of performance enhancing chemistries and surfaces 8 $773M* SALES 26% Performance Chemicals Latex Binders │ Acrylics │ Resins │Hollow Plastic Pigments │ Fluorosurfactants │ Opacifiers │ Bio-Based Polymers Engineered Surfaces Coated Fabrics

  9. Slide 9: Well-Positioned for Strong Continued Earnings Momentum and Cash Generation

    COMPANY CONFIDENTIAL Well-Positioned for Strong Continued Earnings Momentum and Cash Generation 9 Near-term (2016-2017) drivers Medium to longer term (2016-2018+) drivers reversed trend in specialty businesses $0 $50 $100 $150 $200 2010 Adjusted EBITDA Paper / carpet latex erosion Growth in specialt

  10. Slide 10: Goals Reflect Continuing Transition To Specialty Focus

    COMPANY CONFIDENTIAL Goals Reflect Continuing Transition To Specialty Focus Adjusted Segment Operating Margin* 6.9% 8.9% Mid Teens *Non-GAAP adjusted values, GAAP reconciliation in the appendix. 10 2014 2015 Goal Growth: 2X Underlying Specialty Markets › Specialty Volume Growth › High Margin New Pro

  11. Slide 11: Our Value-Creating Strategic Priorities

    COMPANY CONFIDENTIAL Drive Improved Return On Investment Accelerate Growth In Specialty Businesses Deploy a Balanced Capital Allocation Policy Our Value-Creating Strategic Priorities How we’ll get there 11 OPERATIONAL FINANCIAL Expand Margins, Generate Cash In Performance Materials Businesses

  12. Slide 12: Accelerate Growth In Specialty Businesses

    COMPANY CONFIDENTIAL Accelerate Growth In Specialty Businesses Grow specialty greater than underlying markets 12 Targeting Specialty Growth Markets › Higher growth, higher margin businesses › Strong position from which to build…significant opportunities to grow share › Footprint actions enhance spec

  13. Slide 13: Specialty Growth: Targeted Markets

    COMPANY CONFIDENTIAL Specialty Growth: Targeted Markets Targeting robust markets with demand for high performance, high margin products 13 % = Estimated Market Growth Rate *Market data based on internal estimates and OMNOVA’s place in the value chain. PC ES PC PC/ES PC PC ES Common characteristics:

  14. Slide 14: Diversifying Chemistries & Geographies

    COMPANY CONFIDENTIAL 80% 39% 20% 61% Pre-2010 2015 87% 59% 11% 20% 2% 21% Pre- 0 2015 Diversifying Chemistries & Geographies Increased access to specialty markets 14 Other Chemistries SB Latex Asia Europe N. America Diversifying Chemistries & Markets in Performance Chemicals Total OMNOVA Global Expa

  15. Slide 15: OMNOVA Performance Enhancing Product Development

    COMPANY CONFIDENTIAL OMNOVA Performance* Enhancing Product Development Examples of recent new product platform innovations 15 New team, new processes, improved outcomes Softwick Finishing treatment for disposables › Superior fluid management › Less bulk, weight, cost › Excellent softness › Broad mar

  16. Slide 16: Expand Margins, Generate Cash In Performance Materials Businesses

    COMPANY CONFIDENTIAL Strengthening Customer Relationships › Capture growth in carpet and non-carpet flooring › Greater focus on higher growth specialty paper/packaging segments › Value-based pricing Expand Margins, Increase Cash Generation In Performance Materials Businesses 16 Performance Materials

  17. Slide 17: Performance Materials Manufacturing Realignment and SG&A Restructuring

    COMPANY CONFIDENTIAL 17 Performance Materials Manufacturing Realignment and SG&A Restructuring Work substantially completed during 2Q 2016 – Savings on track ~300M lbs N. America SB capacity reduction >90% N. America SB capacity utilization (previously 62%) $14M - $17M in expected annual operating s

  18. Slide 18: Drive Improved Return On Investment

    COMPANY CONFIDENTIAL Drive Improved Return On Investment Driving to returns in excess of cost of capital 18 Lowering Our Cost Base › Increased capacity utilization › Footprint optimization › Repurposing to specialty › Cost reductions › LEAN SixSigma Managing Working Capital › Significant reduction o

  19. Slide 19: Successful implementation of our business strategy beginning to bear fruit

    COMPANY CONFIDENTIAL Successful implementation of our business strategy beginning to bear fruit… › Accelerating growth in Specialty businesses › Expanding margins, generating cash in Performance Materials businesses › Driving improved return on investment and balancing capital allocation …amidst pos

  20. Slide 20: Deploy a Balanced Capital Allocation Policy

    COMPANY CONFIDENTIAL Deploy a Balanced Capital Allocation Policy Strategy 20 Strategic Growth Investments › Bolt-on M&A to support specialty businesses › Funded by growth in EBITDA and cash flow Disciplined Approach to Capital Spending › Focused on key growth markets De-Levering Business › Targeting

  21. Slide 21: Record of Cash Generation and De-Leveraging

    COMPANY CONFIDENTIAL 21 Consistent deleveraging since Eliokem acquisition Record of Cash Generation and De-Leveraging Refinance completed in Q3 2016 Reduced gross debt by ~$89M since 2011 Disciplined balance sheet management › Redeemed $50M of bonds in November 2014 and November 2015 respectively wi

  22. Slide 22: Capital Structure / Liquidity / Net Leverage

    COMPANY CONFIDENTIAL Capital Structure / Liquidity / Net Leverage Liquidity Revolver $64 • Balance Drawn • Letters of Credit $0 $0 Remaining Capacity $64 Cash** $70 Total Liquidity $134 22 As of August 31, 2016 (In millions) Third quarter debt cost ~ 5.8% / sufficient liquidity Net Leverage Ratio To

  23. Slide 23: History of Taking Decisive Action

    COMPANY CONFIDENTIAL 23 History of Taking Decisive Action Strategic portfolio actions to drive shareholder value Proactive actions partially offset headwinds in performance materials businesses • Access to fast- growing Asian markets • Upgrade capabilities • Low-cost manufacturing • Expand global ma

  24. Slide 24: Engineered Surfaces Adjusted Segment Operating Profit

    COMPANY CONFIDENTIAL Engineered Surfaces Adjusted Segment Operating Profit ($M)* 24 Engineered Surfaces transformation provides model for Performance Chemicals Strong cash and profitability contributor 2011 Key Actions › Strategically sold market-impaired wallcovering business › Closed and consolida

  25. Slide 25: Why OMNOVA Solutions?

    COMPANY CONFIDENTIAL › Exciting opportunities to grow higher margin Specialty businesses › Strengthened innovation and commercial excellence process › Positive momentum in margin expansion, earnings growth and cash generation › Significantly lowered cost base and reconfigured manufacturing footprint

  26. Slide 26: OMNOVA Solutions

    OMNOVAY SOLUTIONS

  27. Slide 27: Lower Raw Material Costs and Performance Features Contribute to Cost-in-Use Advantage

    COMPANY CONFIDENTIAL 0 30 60 90 120 150 Ce nts pe r lb 27 SB Lower Raw Material Costs and Performance Features Contribute to Greater Cost-in-Use Advantage SB latex has returned to historical cost advantaged position Comparison of N.A. raw material input costs (only) of emulsion polymer systems 2000-

  28. Slide 28: Total Company Sales by End Market

    COMPANY CONFIDENTIAL Total Company Sales by End Market 28 Refurbishment & new construction 40% Paper and packaging 15% Transportation 21% Industrial / Other 11% Personal hygiene 7% Oilfield 6% Note: Financials breakdown as of 2015 FYE. Financials inclusive of Indian rubber business sold in Q1 2016.

  29. Slide 29: Non-GAAP Financial Measures

    COMPANY CONFIDENTIAL This presentation includes Adjusted Segment Operating Profit, Adjusted Segment EBITDA, Adjusted Income from Continuing Operations Before Income Taxes, Adjusted Consolidated EBITDA and other financial measures which are Non-GAAP financial measures as defined by the Securities and

  30. Slide 30: Reconciliation of Reported Segment Sales and Operating Profit to Net Sales and Net Income

    COMPANY CONFIDENTIAL Appendix 1 – Reconciliation of Reported Segment Sales and Operating Profit to Net Sales and Net (Loss) Income 30 (In millions) 2016 2015 2016 2015 Net Sales Performance Chemicals Performance Materials 71.5$ 83.0$ 215.5$ 252.9$ Specialty Chemicals 72.0 70.6 200.0 214.1 Total Perf

  31. Slide 31: Appendix – Performance Chemicals

    COMPANY CONFIDENTIAL Appendix 2 – Performance Chemicals 31 (Dollars in millions except per share data) 2012 2013 2014 2015 *LTM Sales $ 864.5 $ 773.0 $ 746.5 $ 608.1 $ 556.6 Segment Operating Profit $ 89.6 $ 64.1 $ 46.2 $ 15.9 $ 30.9 Management Excluded Items Restructuring and severance - 2.1 0.5 4.

  32. Slide 32: Appendix – Engineered Surfaces

    COMPANY CONFIDENTIAL Appendix 3 – Engineered Surfaces 32 (Dollars in millions except per share data) 2012 2013 2014 2015 *LTM Sales $ 261.0 $ 245.1 $ 241.1 $ 229.9 $ 216.3 Segment Operating Profit $ 3.8 $ 15.6 $ 19.2 $ 18.9 $ 18.5 Interest Expense - - - - - Inc (loss) From Continuing Operations befo

  33. Slide 33: Appendix – OMNOVA Consolidated

    COMPANY CONFIDENTIAL Appendix 4 – OMNOVA Consolidated 33 (Dollars in millions except per share data) 2012 2013 2014 2015 *LTM Sales $ 1,125.5 $ 1,018.1 $ 987.4 $ 838.0 $ 772.9 PC Adjusted Segment Operating Profit $ 89.6 $ 67.1 $ 49.9 $ 52.2 $ 61.8 ES Adjusted Segment Operating Profit 9.3 17.7 18.5 2

  34. Slide 34: Consolidated Adjusted EBITDA By Quarter

    COMPANY CONFIDENTIAL Appendix 5 – Consolidated Adjusted EBITDA By Quarter 34 (Dollars in millions except per share data) 1st QTR 2nd QTR 3rd QTR 4th QTR 1st QTR 2nd QTR 3rd QTR Sales 206.9$ 220.2$ 210.9$ 200.0$ 175.3$ 202.0$ 195.6$ Segment Operating Profit / Corporate Expense 2.4$ 10.5$ 6.7$ (12.4)$

  35. Slide 35: LTM Consolidated Adjusted EBITDA By Quarter

    COMPANY CONFIDENTIAL Appendix 6 – LTM Consolidated Adjusted EBITDA By Quarter 35 1st QTR 2nd QTR 3rd QTR 4th QTR 1st QTR 2nd QTR 3rd QTR (Dollars in millions except per share data) LTM LTM LTM LTM LTM LTM LTM Sales 968.4$ 922.2$ 881.0$ 838.0$ 806.4$ 788.2$ 772.9$ Segment Operating Profit / Corporate

  36. Slide 36: Adjusted Return on Invested Capital

    COMPANY CONFIDENTIAL Appendix 7 – Adjusted Return on Invested Capital 36 (In millions) Trailing Twelve Months Ended August 31, Adjusted Net Operating Profit after Tax 2016 2015 2014 Adjusted Income from Continuing Operations 22.0$ 16.5$ 12.9$ Interest add back excluding debt premium 24.2 27.3 30.9 T

  37. Slide 37: OMNOVA Solutions

    OMNOVAY _SOLUTIONS

Omnova Solutions — Investor Presentation (September 2016) on 6ix